We would like to thank Dr Sezin Yuce Sari and his colleagues for their interest and comments on our recent publication on Clinical Target Volume (CTV) delineation for primary Head & Neck squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx and larynx [1]. To avoid any misunderstanding and/or misinterpretation of our recent guidelines, we would like to reply point by point to their criticism.
https://ift.tt/2Fnzeu5
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου